SPL 0.00% 9.5¢ starpharma holdings limited

Ann: VivaGel BV NDA advances to next stage of FDA review, page-10

  1. 903 Posts.
    lightbulb Created with Sketch. 91
    very happy to have topped up with an additional 10k at this price. Just a reminder here of the additional 5 years market exclusivity as part of Fast Track, put a number on that in the distributor negotiations!

    QIDP designation was created by the Generating Antibiotic Incentives Now (GAIN) Act and provides incentives for the development of new antimicrobial products. These incentives include priority regulatory review and an additional five years’ of market exclusivity.

    and if you take a look at the the current course of sales, it looks like heavy bot activity, do not get sucked into selling
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢
Change
0.000(0.00%)
Mkt cap ! $39.64M
Open High Low Value Volume
9.7¢ 9.7¢ 9.5¢ $19.64K 204.3K

Buyers (Bids)

No. Vol. Price($)
2 69731 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 5390 1
View Market Depth
Last trade - 16.10pm 09/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.